Reversal of red cell aplasia and marrow fibrosis in non-Hodgkin's lymphoma.
Red cell aplasia and marrow fibrosis occurred in a 34-year-old man with diffuse well differentiated lymphocytic lymphoma. Complete recovery of marrow function and histology with remission of the lymphoproliferative malignancy were observed following 6 courses of combination chemotherapy.
D000328:Adult; D000741:Anemia, Aplastic / Q000188:drug therapy* / Q000209:etiology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000150:complications / Q000188:drug therapy*; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D055728:Primary Myelofibrosis / Q000188:drug therapy* / Q000209:etiology; D011344:Procarbazine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D011344:Procarbazine; D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone